FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
Contenu indisponible. Consultez la source originale.
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.